Trial of Ondansetron as a Parkinson's HAllucinations Treatment

NCT04167813 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

168

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Hallucinations
Dementia With Lewy Bodies

Interventions

DRUG: Ondansetron 8mg or matched placebo tablets

Sponsor

University College, London

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]